Thursday, February 5, 2026
|
|
|
Earnings season is the heartbeat of the market, and every day brings fresh signals about where money is flowing. With each report, we learn not just how companies are performing, but how investors are reacting. In the Daily Beat, we spotlight the most important S&P 500 earnings moves from the prior session: the winners, the losers, and the reactions that reveal what really matters to the market right now. Whether it's a bellwether with broad economic implications or a niche name making waves, we cut through the noise to focus on the setups that matter most. |
|
|
Here are the top beats from the S&P 500 👇 |
|
|
*Click the image to enlarge it Wednesday's top beat came from the $19B scientific and technical instruments stock, Fortive $FTV. After beating expectations across the board, shareholders were rewarded with a +6.27 reaction score. This was the stock's best earnings reaction ever. In the report, FTV posted revenues of $1.12B, beating the expected $1.09B, and earnings per share were $0.90, above the expected $0.84. The beat/beat/pop from the world's largest healthcare stock, Eli Lilly $LLY, also stood out to us. Check out the latest Weekly Beat column for more on LLY. |
|
|
Here are the bottom beats from the S&P 500 👇 |
|
|
*Click the image to enlarge it Wednesday's bottom beat came from the $112B medical devices stock, Boston Scientific $BSX. After beating headline expectations across the board, shareholders suffered a -11.04 reaction score. This was one of the biggest beat/beat/drops we've seen all season. BSX reported revenues of $5.29B, beating the expected $5.28B, and earnings per share of $0.80, beating the expected $0.78. The beatdowns in Advanced Micro Devices $AMD and Uber $UBER also stood out to us. Let's talk about what else happened 👇 |
|
|
FTV had its best earnings reaction ever🔥 |
|
|
Fortive had a +10.6% post-earnings reaction, and here's what happened: |
|
|
- Looking at revenue, the intelligent operating solutions segment outperformed, growing 5.3% year-over-year.
- Earnings per share surged 12.5% year-over-year, and the management team expects a similar growth rate in 2026.
- The company repurchased 8% of its outstanding shares in 2025, making it one of the top share cannibals in the S&P 500.
|
|
|
Not only did Fortive beat the headline expectations, but it also crushed the market's expectations. This is why the stock had its best earnings reaction ever. This was likely the initiation thrust for a brand-new primary uptrend in the stock. As you can see, FTV is in the later stages of a prolonged accumulation pattern that dates back to 2018. And with the dramatic change in earnings sentiment this quarter, we expect the technicals to confirm the strong fundamentals. We're looking for the buyers to make a run for new all-time highs soon. |
|
|
BSX had its worst earnings reaction since 2000🐻 |
|
|
Boston Scientific had a -17.6% post-earnings reaction, and here's what happened: |
|
|
- Net sales surged 15.9% year-over-year, driven by major new product launches and acquisitions.
- The watchman segment outperformed, growing sales by 29.4% year-over-year.
- In addition to the solid quarterly results, the management team issued strong forward guidance across the board.
|
|
|
For years, Boston Scientific has been a leader in the medical devices industry. However, this role is changing in real time as the stock decisively resolves a textbook distribution pattern on the heels of a beat/beat/drop. And when we say decisive, we mean it. This was the stock's worst earnings reaction since 2000. With the technicals and fundamentals in strong primary downtrends, we expect BSX to trend lower for the foreseeable future. Stay tuned for more earnings reactions tomorrow. -The Beat Team |
|
|
Editor's Note: Due to popular demand, Steve Strazza is going live TODAY at 2 pm ET to answer your questions about his new Beat Report research. Whether you made it to last week's event or not, this will be must-see TV on Stock Market TV. We hope to see you there! |
|
|
STAY HUNGRY. STAY FOOLISH |
| |
|
Stock Market Media emails are a financial publication of general circulation and only offers impersonal advice, not tailored to individual needs of a specific client or group. Any comments or statements made herein do not necessarily reflect those of Stock Market Media LLC or its affiliates (collectively, "Stock Market Media") and do not constitute buy or sell recommendations. Unless specifically indicated, this message is not an official confirmation of any transaction. The contents of any email communications to or from Stock Market Media may be monitored or reviewed at Stock Market Media's discretion. Stock Market Media accepts no responsibility for any loss or damage arising in any way from the use of this transmission and any attachments; it is the responsibility of the recipient to ensure that they are virus free. If you reply to this email, please note that we are a public investor and do not want any material non-public information. We do not agree to keep confidential any information you provide and do not agree to any restrictions on our trading activity, except pursuant to a written confidentiality agreement executed by Stock Market Media. |
Want to change how you receive these emails? You can manage your preferences here unsubscribe.
© 2026 Stock Market Media 624 Broadway, Suite 405 San Diego, CA 92101 |
Stock Market Media 624 Broadway Suite 405 San Diego, CA 92101 |
|
|
|
_01KGPX2WB1KKY43RR72TQRD4Z5.png)
_01KGPX2VZJ7JEKGVC6CFKSDXF7.png)
_01KGPX2V3WKE7B1BR89RBXS8W2.png)
_01KGPX2VNB97CCZJDAS944A8XG.png)
